Basis: Trailing twelve months (TTM net income over the latest quarterly balance sheet). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on assets (ROA) high or low?
The return on assets (ROA) of 7.50% is 73% above its 5-year average of 4.33%, near the high end of its 5-year range (0.99%–7.50%).
12.19% above its 12-month average of 6.68%.
Reported quarterly return on assets; no daily interpolation. Q1 FY2027 (2026-06-30): 1.86%.
RETURN ON ASSETS (ROA)
7.50%
RETURN ON ASSETS (ROA) AVG TTM
6.68%
RETURN ON ASSETS (ROA) AVG 3Y
4.44%
RETURN ON ASSETS (ROA) AVG 5Y
4.33%
RETURN ON ASSETS (ROA) AVG 10Y
4.48%
RETURN ON ASSETS (ROA) AVG 15Y
5.31%
RETURN ON ASSETS (ROA) AVG 20Y
5.87%
CURRENT VS TTM AVG
+12.19%
CURRENT VS 3Y AVG
+68.73%
CURRENT VS 5Y AVG
+73.41%
CURRENT VS 10Y AVG
+67.27%
CURRENT VS 15Y AVG
+41.23%
CURRENT VS 20Y AVG
+27.68%
SECTOR MEDIAN · HEALTHCARE
5.14%
median of 90 covered companies
CURRENT VS SECTOR MEDIAN
+45.91%
vs the sector median at left
Market Cap
$20.29B
Return on Assets (ROA)
-1.17%
TTM Avg
-5.49%
3Y Avg
-1.68%
5Y Avg
-1.68%
Market Cap
$20.04B
Return on Assets (ROA)
18.16%
TTM Avg
16.59%
3Y Avg
14.73%
5Y Avg
13.22%
Market Cap
$17.35B
Return on Assets (ROA)
3.54%
TTM Avg
3.64%
3Y Avg
3.29%
5Y Avg
2.38%
Market Cap
$17.32B
Return on Assets (ROA)
23.89%
TTM Avg
21.05%
3Y Avg
19.32%
5Y Avg
16.45%
Market Cap
$16.81B
Return on Assets (ROA)
1.97%
TTM Avg
2.19%
3Y Avg
1.89%
5Y Avg
3.83%
Market Cap
$24.93B
Return on Assets (ROA)
-8.40%
TTM Avg
-3.96%
3Y Avg
9.16%
5Y Avg
17.06%
Market Cap
$25.22B
Return on Assets (ROA)
20.48%
TTM Avg
9.54%
3Y Avg
8.43%
5Y Avg
7.44%
Market Cap
$25.33B
Return on Assets (ROA)
5.41%
TTM Avg
4.41%
3Y Avg
4.42%
5Y Avg
6.18%
| NAME | MARKET CAP | RETURN ON ASSETS (ROA) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| STERIS plc (STE) | $20.35B | 7.50% | 6.68% | 4.44% | 4.33% |
| Viatris Inc. (VTRS)vs › | $20.29B | -1.17% | -5.49% | -1.68% | -1.68% |
| United Therapeutics Corporation (UTHR)vs › | $20.04B | 18.16% | 16.59% | 14.73% | 13.22% |
| Zimmer Biomet Holdings, Inc. (ZBH)vs › | $17.35B | 3.54% | 3.64% | 3.29% | 2.38% |
| Medpace Holdings, Inc. (MEDP)vs › | $17.32B | 23.89% | 21.05% | 19.32% | 16.45% |
| Revvity, Inc. (RVTY)vs › | $16.81B | 1.97% | 2.19% | 1.89% | 3.83% |
| BioNTech SE (BNTX)vs › | $24.93B | -8.40% | -3.96% | 9.16% | 17.06% |
| Incyte Corporation (INCY)vs › | $25.22B | 20.48% | 9.54% | 8.43% | 7.44% |
| Labcorp Holdings Inc. (LH)vs › | $25.33B | 5.41% | 4.41% | 4.42% | 6.18% |
| Solventum Corporation (SOLV)vs › | $15.34B | 10.07% | 7.10% | 8.43% | 7.35% |
ROA
7.5%
ROE
11.2%
ROA = Net Income / Total Assets
Return on assets measures how efficiently a company generates profit from its total assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON ASSETS (ROA) |
|---|---|
| 2026-03-31 | 7.31% |
| 2025-03-31 | 6.06% |
| 2024-03-31 | 3.42% |
| 2023-03-31 | 0.99% |
| 2022-03-31 | 2.13% |
| 2021-03-31 | 6.04% |
| 2020-03-31 | 7.49% |
| 2019-03-31 | 5.99% |
| 2018-03-31 | 5.59% |
| 2017-03-31 | 2.23% |
| 2016-03-31 | 2.07% |
| 2015-03-31 | 6.44% |
| 2014-03-31 | 6.86% |
| 2013-03-31 | 9.08% |
| 2012-03-31 | 9.68% |
| 2011-03-31 | 3.59% |
| 2010-03-31 | 10.37% |
| 2009-03-31 | 9.10% |
| 2008-03-31 | 6.22% |
| 2007-03-31 | 6.79% |
| 2006-03-31 | 5.91% |
| 2005-03-31 | 7.25% |
| 2004-03-31 | 8.82% |
| 2003-03-31 | 8.88% |
| 2002-03-31 | 5.49% |
| 2001-03-31 | 0.16% |
| 2000-03-31 | 1.16% |
| 1999-03-31 | 9.80% |
| 1998-03-31 | 8.94% |
| 1997-03-31 | -5.67% |
